Investigational Site Number : 1560040

Hangzhou 310003

1 studies enrolling now · 1 studies all time

What they study most

Type 1 Diabetes Mellitus

Studies at this site

• A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes — Recruiting now